申请人:GENENTECH, INC.
公开号:US20020035104A1
公开(公告)日:2002-03-21
Provided are compounds of formula (I)
1
wherein A, Q, W, X, Y, Z, R
1
to R
4
, m and n are as defined herein. Compounds of the invention bind to &agr;
4
integrin receptors and thereby inhibit binding of ligands for &agr;
4
integrins which is useful for prophylactic and/or therapeutic treatment of diseases and conditions associated with &agr;
4
integrins or their ligands.
提供的是式(I)1的化合物,其中A、Q、W、X、Y、Z、R1至R4、m和n的定义如本文所述。本发明的化合物结合到α4整合素受体,从而抑制α4整合素的配体结合,这对于预防和/或治疗与α4整合素或其配体相关的疾病和症状是有用的。